Dynatronics Corporation (DYNT): Price and Financial Metrics
GET POWR RATINGS... FREE!
DYNT Price/Volume Stats
Current price | $0.86 | 52-week high | $4.30 |
Prev. close | $0.84 | 52-week low | $0.73 |
Day low | $0.85 | Volume | 48,600 |
Day high | $0.89 | Avg. volume | 20,714 |
50-day MA | $1.31 | Dividend yield | N/A |
200-day MA | $2.10 | Market Cap | 3.47M |
DYNT Stock Price Chart Interactive Chart >
DYNT Stock Summary
- With a market capitalization of $3,316,761, DYNATRONICS CORP has a greater market value than only 0.54% of US stocks.
- DYNT's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.09 -- higher than merely 1.61% of US-listed equities with positive expected earnings growth.
- DYNT's price/sales ratio is 0.08; that's higher than the P/S ratio of just 1.64% of US stocks.
- Stocks that are quantitatively similar to DYNT, based on their financial statements, market capitalization, and price volatility, are LL, CGA, ETD, FOSL, and CTHR.
- Visit DYNT's SEC page to see the company's official filings. To visit the company's web site, go to www.dynatronics.com.
DYNT Valuation Summary
- DYNT's price/sales ratio is 0.1; this is 98.04% lower than that of the median Healthcare stock.
- DYNT's price/sales ratio has moved down 0.3 over the prior 243 months.
Below are key valuation metrics over time for DYNT.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
DYNT | 2023-05-23 | 0.1 | 0.2 | -0.7 | -2.2 |
DYNT | 2023-05-22 | 0.1 | 0.2 | -0.7 | -2.1 |
DYNT | 2023-05-19 | 0.1 | 0.2 | -0.7 | -2.1 |
DYNT | 2023-05-18 | 0.1 | 0.2 | -0.7 | -2.1 |
DYNT | 2023-05-17 | 0.1 | 0.2 | -0.6 | -2.1 |
DYNT | 2023-05-16 | 0.1 | 0.2 | -0.6 | -2.1 |
DYNT Growth Metrics
- Its 5 year revenue growth rate is now at 85.81%.
- Its 2 year cash and equivalents growth rate is now at 61.67%.
- Its 2 year revenue growth rate is now at -25.36%.

The table below shows DYNT's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 44.4435 | -2.183071 | -5.091834 |
2022-09-30 | 44.0908 | -3.865095 | -5.701259 |
2022-06-30 | 44.33849 | -4.884425 | -4.726499 |
2022-03-31 | 45.38457 | -3.18997 | -0.230384 |
2021-12-31 | 46.52873 | -4.658405 | 1.359578 |
2021-09-30 | 47.96678 | -1.395919 | 2.076729 |
DYNT's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- DYNT has a Quality Grade of C, ranking ahead of 58.1% of graded US stocks.
- DYNT's asset turnover comes in at 1.247 -- ranking 12th of 186 Medical Equipment stocks.
- IRMD, ELMD, and NUVA are the stocks whose asset turnover ratios are most correlated with DYNT.
The table below shows DYNT's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 1.247 | 0.270 | 0.109 |
2021-03-31 | 1.151 | 0.274 | -0.133 |
2020-12-31 | 1.193 | 0.274 | -0.178 |
2020-09-30 | 1.241 | 0.282 | -0.145 |
2020-06-30 | 1.302 | 0.283 | -0.118 |
2020-03-31 | 1.464 | 0.300 | -0.046 |
DYNT Price Target
For more insight on analysts targets of DYNT, see our DYNT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $2.00 | Average Broker Recommendation | 1.33 (Strong Buy) |
Dynatronics Corporation (DYNT) Company Bio
Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. It offers orthopedic soft bracing products, which include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also provides power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, recumbent bikes, and other related equipment. In addition, it offers therapeutic modality devices, such as electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. Further, the company provides clinical supplies, including exercise bands and tubing, topical analgesics, lotions and gels, orthopedic bracing, paper products, athletic tapes, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, and athletic trainers, sports medicine practitioners, hospitals, clinics, and consumers, as well as online. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Eagan, Minnesota.
Latest DYNT News From Around the Web
Below are the latest news stories about DYNATRONICS CORP that investors may wish to consider to help them evaluate DYNT as an investment opportunity.
Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After TransitionConsistency of Executive Leadership Expected to Provide Smooth Transition Eagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ: DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Ch |
Need To Know: The Consensus Just Cut Its Dynatronics Corporation (NASDAQ:DYNT) Estimates For 2024One thing we could say about the analysts on Dynatronics Corporation ( NASDAQ:DYNT ) - they aren't optimistic, having... |
Q3 2023 Dynatronics Corp Earnings CallQ3 2023 Dynatronics Corp Earnings Call |
Dynatronics Corporation (DYNT) Reports Q3 Loss, Misses Revenue EstimatesDynatronics Corporation (DYNT) delivered earnings and revenue surprises of -125% and 11.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? |
Dynatronics Corporation Reports Third Quarter Fiscal Year 2023 Financial Results and Business HighlightsEagan, Minnesota--(Newsfile Corp. - May 11, 2023) - Dynatronics Corporation (NASDAQ: DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its third quarter of fiscal year 2023 ended March 31, 2023, and provided an update on the business.CEO Commentary"Dynatronics experienced revenue challenges in our third fiscal quarter as a result of three external factors. As a result, we are adjusting |
DYNT Price Returns
1-mo | -39.01% |
3-mo | -54.74% |
6-mo | -60.01% |
1-year | N/A |
3-year | -74.13% |
5-year | -94.12% |
YTD | -55.91% |
2022 | -60.99% |
2021 | 23.46% |
2020 | -2.42% |
2019 | -69.59% |
2018 | -5.21% |
Continue Researching DYNT
Want to see what other sources are saying about Dynatronics Corp's financials and stock price? Try the links below:Dynatronics Corp (DYNT) Stock Price | Nasdaq
Dynatronics Corp (DYNT) Stock Quote, History and News - Yahoo Finance
Dynatronics Corp (DYNT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...